bioRxivMolecular BiologyPreprint
FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55/PP2A phosphatase
Jason S. WassermaniD, Bulat FaezoviD, Kishan R. PateliD, Alison KurimchakiD, Seren M. PalacioiD, Holly A. Fowle, Brennan C McEwaniD, Qifang XuiD, Ziran ZhaoiD, Lauren E. CresseyiD, Neil JohnsoniD, James S. DuncaniD, Arminja Nadine KettenbachiD, Roland L. DunbrackiD, Xavier GrañaiD
Abstract
The Ser/Thr protein phosphatase 2A (PP2A) is a highly conserved collection of heterotrimeric holoenzymes responsible for the dephosphorylation of many regulated phosphoproteins. Substrate recognition and the integration of regulatory cues are mediated by B regulatory subunits that are complexed to the catalytic subunit (C) by a scaffold protein (A). PP2A/B55 substrate recruitment was thought to be mediated by charge-charge interactions between the surface of B55 and its substrates. Challenging this view, we recently discovered a conserved SLiM [RK]-V-x-x-[VI]-R in a range of proteins, including substrates such as the retinoblastoma-related protein p107 and TAU (Fowle et al. eLife 2021;10:e63181). Here we report the identification of this SLiM in FAM122A, an inhibitor of B55/PP2A. This conserved SLiM is necessary for FAM122A binding to B55 in vitro and in cells. Computational structure prediction with AlphaFold2 predicts an interaction consistent with the mutational and biochemical data and supports a mechanism whereby FAM122A uses the SLiM in the form of a short -helix to dock to the B55 top groove. In this model, FAM122A spatially constrains substrate access by occluding the catalytic subunit with a second -helix immediately adjacent to helix 1. Consistently, FAM122A functions as a competitive inhibitor as it prevents binding of substrates in in vitro competition assays and the dephosphorylation of CDK substrates by B55/PP2A in cell lysates. Ablation of FAM122A in human cell lines reduces the rate of proliferation, progression through cell cycle transitions and abrogates G1/S and intra-S phase cell cycle checkpoints. FAM122A-KO in HEK293 cells results in attenuation of CHK1 and CHK2 activation in response to replication stress. Overall, these data strongly suggest that FAM122A is a SLiM-dependent, substrate-competitive inhibitor of B55/PP2A that suppresses multiple functions of B55 in the DNA damage response and in timely progression through the cell cycle interphase.
- organism: human
- assay: proteomics
- research focus: protein structure prediction
- research focus: protein design
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism
Iker Benavides-Puy, Suzanne Vigneron, … Jakob Nilsson·Journal of Cell SciencePeer-reviewed·Jul 3, 2026
- PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107
- Structural and biochemical studies of human PP2A(B55) holoenzyme and ENSA protein complex
Gang Tian, Xiang Zhang, … Wenqing Xu·bioRxiv·Dec 14, 2025
- Cryo-EM structures of PP2A:B55-Eya3 and PP2A:B55-p107 define PP2A:B55 substrate recruitment
S. K. Padi, R. J. Godek, … R. Page·bioRxiv·Sep 16, 2024
- Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19
S. K. Padi, M. R. Vos, … W. Peti·bioRxiv·Aug 31, 2023
- Cyclin A/cdk activity and FAM122A-dependent inhibition of PP2A-B55 are essential to trigger mitosis.
B. Lacroix, S. Vigneron, … T. Lorca·bioRxiv·Jun 20, 2023